Studies show the COVID-19 vaccines boost the antibody levels and improve the immune response of those who previously had COVID-19. The vaccines do not “wipe out” the antibodies developed by a person who had recovered from the disease, as social media posts have falsely claimed for months.
Featured Posts
PhRMA Ad Misleads on Medicare Drug Negotiation Legislation
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.
Trump’s Final Numbers
Debt Limit Q&A
Ongoing Clinical Trials Will Decide Whether (or Not) Ivermectin Is Safe, Effective for COVID-19
Studies on whether ivermectin is beneficial in treating COVID-19 patients haven’t been conclusive, and health officials have warned people not to self-medicate. But multiple large trials are continuing to assess the antiparasitic drug. Yet, Sen. Rand Paul reportedly said researchers were “unwilling to objectively study” it because of “hatred” for Donald Trump. He later acknowledged studies are being done. Here we review the research.